Transplanting patients with GATA2 deficiency prior to the acquisition of severe infections or secondary organ damage, such as progressive pulmonary disease, is likely to increase long-term survival of adult patients with GATA2 deficiency. This evidence concerns the gene GATA2 and lung disorder.